【発明の名称】CD40を発現する腫瘍細胞を特徴とする疾患の予防又は治療方法

Title:

【発明の名称】CD40を発現する腫瘍細胞を特徴とする疾患の予防又は治療方法

Document Type and Number:

Japanese Patent JPH09507074

Kind Code:

A

Abstract:

There is disclosed a method of treating a mammal afflicted with a disease characterized by neoplastic cells that express CD40, comprising administering a therapeutically effective amount of a CD40 binding protein in a pharmaceutically acceptable buffer. CD40 binding proteins include monoclonal antibodies to CD40, and CD40 ligand. CD40 binding proteins may also be used to prevent disease characterized by neoplastic cells that express CD40, in individuals at risk for such disease.

More Like This:

WO/2003/054141	SPERM-SPECIFIC CATION CHANNEL, CATSPER2, AND USES THEREFOR
WO/2016/112916	ANTIBODIES, COMPOUNDS AND DERIVATIVES THEREOF FOR USE IN THE TREATMENT OF MALE INFERTILITY
WO/2023/026235	ANTI-PSMA ANTIBODIES AND USES THEREOF

Inventors:

Armitage, Richard Jay
Fundslow, William Sea, The Third
Longo, Dan El
Murphy, William Jay

Application Number:

JP51759394A

Publication Date:

July 15, 1997

Filing Date:

December 21, 1994

Export Citation:

Click for automatic bibliography generation Help

Assignee:

IMMUNEX CORPORATION

International Classes:

A61K39/395; A61P35/00; C07K14/47; C07K14/705; C07K16/28; C07K16/30; C07K16/46; C12N15/02; C07K19/00; C12P21/08; A61K38/00; (IPC1-7): A61K39/395; C07K14/47; C07K16/28; C07K16/30; C07K16/46; C07K19/00

Attorney, Agent or Firm:

Kyozo Yuasa (6 people outside)

Previous Patent: 抗菌ふきとり組成物

Next Patent: ロサルタンの多形とロサルタン▲ＩＩ▼形調製のための方法